en

PRODUCT DETAIL

Injexate 50 mg/ml injekčný roztok naplnený v injekčnej striekačke

Code 6695B
MA number 29/0462/15-S
Product Form: sol iru 6x0,40 ml/20 mg (striek.inj.skl.napl. s ihlou)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX03 Methotrexate
Shelf life: 36
Container: pre-filled syringe
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 26.11.2015
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Injexate 50 mg_ml injekčný roztok naplnený v injekčnej striekačke_12.2023.pdf  
PIL: PIL_Injexate 50 mg_ml injekčný roztok naplnený v injekčnej striekačke_03.2024.pdf  
Safety feature Yes
Data update: 31.05.2022
eu-flag.png sk-flag.png